Ligand validation:3MMO

PG6: 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3MMO_PG6_B_529	24%	80%	0.107	0.862	0.53	0.32	-	-	0	0	28%	0.2778
3MMO_PG6_A_529	14%	83%	0.148	0.809	0.57	0.22	-	-	0	0	39%	0.3889
3MMO_PG6_A_533	4%	79%	0.244	0.676	0.49	0.39	-	-	2	0	61%	0.3056
3LG1_PG6_A_532	42%	49%	0.143	0.872	0.83	1.13	-	2	0	0	94%	0.8889
3OWM_PG6_A_529	19%	70%	0.153	0.866	0.62	0.55	-	-	0	0	33%	0.3333
3JR7_PG6_A_299	67%	21%	0.093	0.899	1.78	1.57	5	3	3	0	100%	1
5UL5_PG6_B_604	59%	73%	0.11	0.942	0.49	0.56	-	-	0	0	72%	0.7222
7YUG_PG6_A_401	55%	68%	0.149	0.918	0.41	0.8	-	1	1	0	100%	1
4F7F_PG6_A_202	49%	57%	0.118	0.875	0.59	1.04	-	1	0	0	94%	0.9444
7NB4_PG6_A_403	49%	95%	0.19	0.938	0.23	0.17	-	-	1	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.